DE69605651D1 - Verfahren zur herstellung von trihydrat von 4,10-diacetoxy-2alfa-benzoyloxy-5-beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl ester von (2r,35)-3-benzoylamino-2-hydroxy-3-phenylpropionsäure - Google Patents

Verfahren zur herstellung von trihydrat von 4,10-diacetoxy-2alfa-benzoyloxy-5-beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl ester von (2r,35)-3-benzoylamino-2-hydroxy-3-phenylpropionsäure

Info

Publication number
DE69605651D1
DE69605651D1 DE69605651T DE69605651T DE69605651D1 DE 69605651 D1 DE69605651 D1 DE 69605651D1 DE 69605651 T DE69605651 T DE 69605651T DE 69605651 T DE69605651 T DE 69605651T DE 69605651 D1 DE69605651 D1 DE 69605651D1
Authority
DE
Germany
Prior art keywords
13alfa
2alfa
7beta
diacetoxy
benzoylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69605651T
Other languages
English (en)
Other versions
DE69605651T2 (de
Inventor
Jean-Rene Authelin
Eric Didier
Franck Leveiller
Isabelle Taillepied
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of DE69605651D1 publication Critical patent/DE69605651D1/de
Application granted granted Critical
Publication of DE69605651T2 publication Critical patent/DE69605651T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69605651T 1995-01-25 1996-01-23 Verfahren zur herstellung von trihydrat von 4,10-diacetoxy-2alfa-benzoyloxy-5-beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl ester von (2r,35)-3-benzoylamino-2-hydroxy-3-phenylpropionsäure Expired - Lifetime DE69605651T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500816A FR2729666A1 (fr) 1995-01-25 1995-01-25 Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
PCT/FR1996/000104 WO1996022984A1 (fr) 1995-01-25 1996-01-23 PROCEDE DE PREPARATION DU TRIHYDRATE DU (2R,3S)-3-BENZOYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4,10-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β-DIHYDROXY-9-OXO-TAX-11-EN-13α-YLE

Publications (2)

Publication Number Publication Date
DE69605651D1 true DE69605651D1 (de) 2000-01-20
DE69605651T2 DE69605651T2 (de) 2000-07-06

Family

ID=9475464

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69605651T Expired - Lifetime DE69605651T2 (de) 1995-01-25 1996-01-23 Verfahren zur herstellung von trihydrat von 4,10-diacetoxy-2alfa-benzoyloxy-5-beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl ester von (2r,35)-3-benzoylamino-2-hydroxy-3-phenylpropionsäure

Country Status (43)

Country Link
US (1) US6002022A (de)
EP (1) EP0805806B1 (de)
JP (1) JP3782449B2 (de)
KR (1) KR100384773B1 (de)
CN (1) CN1067997C (de)
AP (1) AP750A (de)
AT (1) ATE187719T1 (de)
AU (1) AU707603B2 (de)
BG (1) BG62769B1 (de)
BR (1) BR9606853A (de)
CO (1) CO4700286A1 (de)
CZ (1) CZ287079B6 (de)
DE (1) DE69605651T2 (de)
DK (1) DK0805806T3 (de)
DZ (1) DZ1977A1 (de)
EE (1) EE03396B1 (de)
ES (1) ES2139332T3 (de)
FI (1) FI119245B (de)
FR (1) FR2729666A1 (de)
GE (1) GEP19991833B (de)
GR (1) GR3032110T3 (de)
HU (1) HU223352B1 (de)
IL (1) IL116903A (de)
IN (1) IN184427B (de)
IS (1) IS2033B (de)
MA (1) MA23782A1 (de)
MY (1) MY113230A (de)
NO (1) NO316987B1 (de)
NZ (1) NZ300958A (de)
OA (1) OA10438A (de)
PE (1) PE64896A1 (de)
PL (1) PL183773B1 (de)
PT (1) PT805806E (de)
RO (1) RO115728B1 (de)
RU (1) RU2154642C2 (de)
SK (1) SK281958B6 (de)
TN (1) TNSN96011A1 (de)
TR (1) TR199700676T1 (de)
TW (1) TW356469B (de)
UA (1) UA47420C2 (de)
UY (1) UY24149A1 (de)
WO (1) WO1996022984A1 (de)
ZA (1) ZA96523B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
EP1947094A3 (de) 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Herstellungsverfahren für Taxanderivate
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
CA2723654A1 (en) * 2008-05-07 2009-11-12 Ivax Research, Llc Processes for preparation of taxanes and intermediates thereof
US8633240B2 (en) * 2012-06-01 2014-01-21 The University Of Utah Research Foundation Paclitaxel trihydrates and methods of making thereof
CN103833693B (zh) * 2014-03-04 2016-02-24 悦康药业集团有限公司 一种紫杉醇化合物及含该紫杉醇化合物的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021662A1 (en) * 1993-03-15 1994-09-29 Yale University Diagnosis of human inflammatory bowel diseases and nucleic acid reagents therefor
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates

Also Published As

Publication number Publication date
RU2154642C2 (ru) 2000-08-20
PL321493A1 (en) 1997-12-08
WO1996022984A1 (fr) 1996-08-01
GEP19991833B (en) 1999-11-05
JPH10512871A (ja) 1998-12-08
CZ287079B6 (en) 2000-08-16
US6002022A (en) 1999-12-14
IS2033B (is) 2005-08-15
IN184427B (de) 2000-08-26
AU4625596A (en) 1996-08-14
FI973105A0 (fi) 1997-07-24
AP750A (en) 1999-07-06
PT805806E (pt) 2000-05-31
IL116903A0 (en) 1996-05-14
UY24149A1 (es) 1996-05-20
IL116903A (en) 2003-01-12
MY113230A (en) 2001-12-31
FR2729666B1 (de) 1997-02-28
PL183773B1 (pl) 2002-07-31
AU707603B2 (en) 1999-07-15
DZ1977A1 (fr) 2002-07-20
TR199700676T1 (xx) 1998-01-21
SK100897A3 (en) 1998-01-14
PE64896A1 (es) 1997-02-23
RO115728B1 (ro) 2000-05-30
EE9700157A (et) 1997-12-15
EP0805806B1 (de) 1999-12-15
DK0805806T3 (da) 2000-05-01
KR100384773B1 (ko) 2003-08-21
BG62769B1 (bg) 2000-07-31
MA23782A1 (fr) 1996-10-01
EP0805806A1 (de) 1997-11-12
GR3032110T3 (en) 2000-03-31
TNSN96011A1 (fr) 2005-03-15
CO4700286A1 (es) 1998-12-29
SK281958B6 (sk) 2001-09-11
NO316987B1 (no) 2004-07-19
CN1169724A (zh) 1998-01-07
NZ300958A (en) 1999-09-29
JP3782449B2 (ja) 2006-06-07
FI973105A (fi) 1997-07-24
DE69605651T2 (de) 2000-07-06
ZA96523B (en) 1996-10-15
ES2139332T3 (es) 2000-02-01
EE03396B1 (et) 2001-04-16
HUP9801437A1 (hu) 1999-09-28
MX9705460A (es) 1997-10-31
FI119245B (fi) 2008-09-15
KR19980701623A (ko) 1998-06-25
FR2729666A1 (fr) 1996-07-26
ATE187719T1 (de) 2000-01-15
NO973247D0 (no) 1997-07-11
AP9701035A0 (en) 1997-07-31
CN1067997C (zh) 2001-07-04
NO973247L (no) 1997-07-11
BR9606853A (pt) 1997-11-25
TW356469B (en) 1999-04-21
HUP9801437A3 (en) 2001-02-28
OA10438A (fr) 2002-03-22
IS4529A (is) 1997-07-22
CZ236297A3 (en) 1997-11-12
UA47420C2 (uk) 2002-07-15
HU223352B1 (hu) 2004-06-28
BG101794A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
DE69609796D1 (de) Verfahren zur herstellung von essigsäure
DE69516188D1 (de) Verfahren zur herstellung von therephthalsäure
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
DE69522479D1 (de) Verfahren zur herstellung von terephtalischer säure
AT399722B (de) Verfahren zur herstellung von mevinolin
ATE187727T1 (de) Verfahren zur herstellung von imidazo- benzodiazepin-derivaten
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
DE69605651D1 (de) Verfahren zur herstellung von trihydrat von 4,10-diacetoxy-2alfa-benzoyloxy-5-beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl ester von (2r,35)-3-benzoylamino-2-hydroxy-3-phenylpropionsäure
DE69628203D1 (de) Verfahren zur herstellung von phenylimidazolin-derivaten
DE69614571D1 (de) Verfahren zur herstellung von lovastatin
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
DE59601895D1 (de) Verfahren zur herstellung von butyrolactonen
DE69516542D1 (de) Verfahren zur herstellung von zimtsäureester-sonnenschutzmitteln
DE69710343D1 (de) Verfahren zur herstellung von fettsäuren
ATE207900T1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
DE69608442D1 (de) Verfahren zur herstellung von 5-formylvelerionsäure
DE69623966D1 (de) Verfahren zur herstellung von enantiomerenreinen azetdin-2-carbonsäuren
DE69610335D1 (de) Verfahren zur herstellung von mercatocarbonsaeuren aus ungesaettigten carbonsaeuren
DE69615836D1 (de) Verfahren zur herstellung von boroxyd
DE69603261D1 (de) Verfahren zur herstellung von 1,2-benzisothiazolonen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC